Pharming Group N.V.
Darwinweg 24
2333 CR Leiden
The Netherlands
VIA EDGAR
December 21, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Alan Campbell and Mary Beth Breslin
| Re: | Pharming Group N.V. |
Acceleration Request for Registration Statement on Form F-1
File No. 333-250984
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Pharming Group N.V. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 22, 2020, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. The Company hereby withdraws its original request for acceleration, dated December 21, 2020, pursuant to which acceleration had previously been requested to 8:00 a.m., Eastern Daylight Time, on December 23, 2020, or as soon as practicable thereafter.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Cooley LLP, by calling Eric Blanchard at (212) 479-6565.
If you have any questions regarding this request, please contact Eric Blanchard of Cooley LLP at (212) 479-6565. Thank you for your assistance with this matter.
| Sincerely, | ||
| PHARMING GROUP N.V. | ||
| By: | /s/ Sijmen de Vries, MD MBA | |
| Sijmen de Vries, MD MBA | ||
| Chief Executive Officer | ||
